Literature DB >> 16648247

The circadian basis of winter depression.

Alfred J Lewy1, Bryan J Lefler, Jonathan S Emens, Vance K Bauer.   

Abstract

The following test of the circadian phase-shift hypothesis for patients with winter depression (seasonal affective disorder, or SAD) uses low-dose melatonin administration in the morning or afternoon/evening to induce phase delays or phase advances, respectively, without causing sleepiness. Correlations between depression ratings and circadian phase revealed a therapeutic window for optimal alignment of circadian rhythms that also appears to be useful for phase-typing SAD patients for the purpose of administering treatment at the correct time. These analyses also provide estimates of the circadian component of SAD that may apply to the antidepressant mechanism of action of appropriately timed bright light exposure, the treatment of choice. SAD may be the first psychiatric disorder in which a physiological marker correlates with symptom severity before, and in the course of, treatment in the same patients. The findings support the phase-shift hypothesis for SAD, as well as suggest a way to assess the circadian component of other psychiatric, sleep, and chronobiologic disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648247      PMCID: PMC1450113          DOI: 10.1073/pnas.0602425103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Prefrontal-subcortical and limbic circuit mediation of major depressive disorder.

Authors:  A L Brody; M W Barsom; R G Bota; S Saxena
Journal:  Semin Clin Neuropsychiatry       Date:  2001-04

2.  Entrainment of free-running circadian rhythms by melatonin in blind people.

Authors:  R L Sack; R W Brandes; A R Kendall; A J Lewy
Journal:  N Engl J Med       Date:  2000-10-12       Impact factor: 91.245

3.  Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports.

Authors:  Arif Khan; Shirin R Khan; Gary Walens; Russell Kolts; Earl L Giller
Journal:  Neuropsychopharmacology       Date:  2002-09-16       Impact factor: 7.853

4.  A circadian signal of change of season in patients with seasonal affective disorder.

Authors:  T A Wehr; W C Duncan; L Sher; D Aeschbach; P J Schwartz; E H Turner; T T Postolache; N E Rosenthal
Journal:  Arch Gen Psychiatry       Date:  2001-12

5.  Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.

Authors:  A W Zobel; T Nickel; A Sonntag; M Uhr; F Holsboer; M Ising
Journal:  J Psychiatr Res       Date:  2001 Mar-Apr       Impact factor: 4.791

6.  A forced desynchrony study of circadian pacemaker characteristics in seasonal affective disorder.

Authors:  Kathelijne M Koorengevel; Domien G M Beersma; Johan A den Boer; Rutger H van den Hoofdakker
Journal:  J Biol Rhythms       Date:  2002-10       Impact factor: 3.182

7.  Circadian time of morning light administration and therapeutic response in winter depression.

Authors:  J S Terman; M Terman; E S Lo; T B Cooper
Journal:  Arch Gen Psychiatry       Date:  2001-01

Review 8.  Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds.

Authors:  L L Judd; H S Akiskal
Journal:  Pharmacopsychiatry       Date:  2000-01       Impact factor: 5.788

Review 9.  Placebo response in studies of major depression: variable, substantial, and growing.

Authors:  B Timothy Walsh; Stuart N Seidman; Robyn Sysko; Madelyn Gould
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

10.  Melatonin treatment for age-related insomnia.

Authors:  I V Zhdanova; R J Wurtman; M M Regan; J A Taylor; J P Shi; O U Leclair
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

View more
  115 in total

1.  Clinical implications of the melatonin phase response curve.

Authors:  Alfred Lewy
Journal:  J Clin Endocrinol Metab       Date:  2010-07       Impact factor: 5.958

Review 2.  Circadian rhythms and mood regulation: insights from pre-clinical models.

Authors:  Colleen A McClung
Journal:  Eur Neuropsychopharmacol       Date:  2011-08-11       Impact factor: 4.600

Review 3.  Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?

Authors:  Horrick Sharma; Soumava Santra; Aloke Dutta
Journal:  Future Med Chem       Date:  2015-11-30       Impact factor: 3.808

4.  Antepartum depression severity is increased during seasonally longer nights: relationship to melatonin and cortisol timing and quantity.

Authors:  Charles J Meliska; Luis F Martínez; Ana M López; Diane L Sorenson; Sara Nowakowski; Daniel F Kripke; Jeffrey Elliott; Barbara L Parry
Journal:  Chronobiol Int       Date:  2013-09-03       Impact factor: 2.877

Review 5.  Even a stopped clock tells the right time twice a day: circadian timekeeping in Drosophila.

Authors:  Ben Collins; Justin Blau
Journal:  Pflugers Arch       Date:  2007-01-17       Impact factor: 3.657

Review 6.  Clock gene variants in mood and anxiety disorders.

Authors:  Timo Partonen
Journal:  J Neural Transm (Vienna)       Date:  2012-04-27       Impact factor: 3.575

Review 7.  Circadian genes, rhythms and the biology of mood disorders.

Authors:  Colleen A McClung
Journal:  Pharmacol Ther       Date:  2007-02-28       Impact factor: 12.310

8.  Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.

Authors:  Robert L Gannon; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2007-08-13       Impact factor: 4.530

9.  Can Circadian Dysregulation Exacerbate Migraines?

Authors:  Jason C Ong; Hannah L Taylor; Margaret Park; Helen J Burgess; Rina S Fox; Sarah Snyder; Jeanetta C Rains; Colin A Espie; James K Wyatt
Journal:  Headache       Date:  2018-05-04       Impact factor: 5.887

Review 10.  Circadian misalignment in mood disturbances.

Authors:  Alfred J Lewy
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.